Amgen (AMGN)
(Delayed Data from NSDQ)
$296.88 USD
+1.78 (0.60%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $296.81 -0.07 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AMGN 296.88 +1.78(0.60%)
Will AMGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMGN
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key Metrics
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for
Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?
Other News for AMGN
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
Amgen Inc (AMGN) Declares Third Quarter 2025 Dividend | AMGN stock news
AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND | AMGN Stock News
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'